We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ANAVEX2-73 Study in Patients With Rett Syndrome (AVATAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03941444
Recruitment Status : Completed
First Posted : May 8, 2019
Last Update Posted : January 27, 2022
Information provided by (Responsible Party):
Anavex Life Sciences Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2021
Actual Study Completion Date : September 30, 2021